More importantly, pathway enrichment analysis suggested that multiple signaling pathways might participate in the tumor-promoting mechanism of silencing RBM10, such as the Wnt/β-catenin pathway, NF-KB pathway, TGF-β pathway (Figure S4C). This evidence concerns the gene NFKB1 and neoplasm.